4//SEC Filing
Waheed Nadia 4
Accession 0001104659-25-013155
CIK 0001393434other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 8:37 PM ET
Size
7.7 KB
Accession
0001104659-25-013155
Insider Transaction Report
Form 4
Waheed Nadia
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-11+237,000→ 237,000 totalExercise: $7.44Exp: 2035-02-10→ Common Stock (237,000 underlying) - Award
Common Stock
2025-02-11+79,000→ 220,666 total
Footnotes (2)
- [F1]On February 11, 2025, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter.
- [F2]Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.
Documents
Issuer
OCULAR THERAPEUTIX, INC
CIK 0001393434
Entity typeother
Related Parties
1- filerCIK 0002023884
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 8:37 PM ET
- Size
- 7.7 KB